Skip to content

Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan

Registry on Post Menopausal Osteoporosis in Gynecology Setting in Pakistan (REPOSE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02422069
Enrollment
624
Registered
2015-04-21
Start date
2010-04-30
Completion date
2011-12-31
Last updated
2016-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal Osteoporosis

Brief summary

This observational study will provide an opportunity to document local patterns of susceptibility, patient profile, and usefulness of screening in postmenopausal patients coming to gynecology outpatient clinics in Pakistan. This will also capture the initial management of PMO in diagnosed patients. The information gathered will serve as a foundation for developing national guidelines on screening and management of PMO in Pakistan.

Interventions

None listed

Sponsors

Hoffmann-La Roche
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Postmenopausal women * Age 50 years or greater

Exclusion criteria

* Previously diagnosed osteoporosis, or receiving treatment for osteoporosis

Design outcomes

Primary

MeasureTime frame
Percentage of patients diagnosed with PMO based upon dual-energy X-ray absorptiometry (DXA) resultsUp to 12 months

Secondary

MeasureTime frame
Use of various PMO treatment modalitiesUp to 12 months

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026